United Therapeutics Corporation (UTHR)
NASDAQ·Healthcare·Biotechnology
$551.00
+0.50%
Mkt Cap $23.27B
Analyst Ratings
Buy
11
Hold
5
Sell
0
Price Target (33 analysts)
$579.83
Range $447.00 – $645.00
Implied Upside
+5.2%
Consensus $579.83 vs current $551.00